Stock ALEXZA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Alexza Pharmaceuticals, Inc.

Equities

US0153842093

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Alexza Pharmaceuticals, Inc.

Managers

Managers TitleAgeSince
Stacy Palermini DFI
 Director of Finance/CFO - 02-12-31
Tatjana Naranda PSD
 President - 04-12-31
Wolfgang Schmidt PRN
 Corporate Officer/Principal - 19-04-30

Members of the board

Members of the board TitleAgeSince
Jorge Ramentol Massana BRD
 Director/Board Member - 16-06-20
Joan Fanés Trillo BRD
 Director/Board Member - 16-06-20
Sergio Ferrer-Salat Serra di Migni BRD
 Director/Board Member - 16-06-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,750,615 17,090,456 ( 78.57 %) 0 78.57 %

Shareholders

NameEquities%Valuation
RhumbLine Advisers LP
-
0 - - $
Manulife Investment Management Ltd.
-
0 - - $

Company contact information

Alexza Pharmaceuticals, Inc.

2091 Stierlin Court

94303, Mountain View

+

http://www.alexza.com
address Alexza Pharmaceuticals, Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Alexza Pharmaceuticals, Inc.